Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Jun 2025 for Vivoryon Therapeutics N.V.. Read the official filing
Filing timeline
BuySaleC. Lohmann
Insider track record
Disclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
C. Lohmann: trading record in brief
C. Lohmann appears in our data through filings on Vivoryon Therapeutics N.V. shares, published by AFM. In total, 3 filings cover trades dated from 22 June 2022 to 30 June 2025.
No open-market sale appears; the market trades are 3 purchases. No amount is published for 3 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2025, the count stands at 1 purchase and no sales.
The newest entry dates from 30 June 2025: an open-market purchase, in Vivoryon Therapeutics N.V. These figures are compiled from regulatory filings published by AFM. They describe what insiders did and are not a recommendation.
Companies and markets linked to C. Lohmann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
25,000 shares0OptieAFM:176907
Canonical exit: 28 Sept 2025 (T+90)
25,000 shares0OptieAFM:160248
Canonical exit: 19 Sept 2024 (T+90)
90,000 shares0OptieAFM:144121
Canonical exit: 20 Sept 2022 (T+90)
3 of 3 declarations
